Coated Endotracheal Tube Market (Updated Version Available)

The Coated Endotracheal Tube market was valued at xxx million USD with a CAGR xx% from 2015-2019. Subsequently, it will touch xxx million USD in 2020 with a CAGR xx % from 2020 to 2025.
Endotracheal tubes are medical devices used for intubation into the trachea to maintain an open airway and to administer certain drugs. There are used for mechanical ventilation, thus there is risk for microbial invasion into the airways. Therefore, to prevent or reduce the incidence of hospital acquired infection or ventilator-associated pneumonia (VAP), endotracheal tubes are coated with a drug-releasing coating that releases antimicrobial agents to inhibit bacterial growth and biofilm formation. Coated endotracheal tube includes variety of endotracheal tubes coated with drugs or materials, which offer antimicrobial properties to endotracheal tube. Coatings include heparin, silver, chlorhexidine, rifampicin, and minocycline agents.
Coated endotracheal tubes are advantageous because coatings have a broad-spectrum antimicrobial activity in vitro, that reduces bacterial adhesion and restricts the biofilm formation on the tube surface. This in turn blocks the occurrence of type of hospital-associated infection called ventilator-associated pneumonia. Ventilator-associated pneumonia (VAP) is a type of infection that mainly occurs in patients with mechanical ventilation and it is caused due to the growth of microorganism on the surface of air management devices, thereby causing illness. According to the infectious diseases society of America/American thoracic society guidelines, 2016, VAP develops 48‐72 hours after endotracheal intubation. Moreover, VAP affects 28% of patients who are on mechanical ventilation. Therefore, VAP is an important source of morbidity and mortality in critically ill patients. The mortality rate attributed to VAP is 27% and as high as 43% when the causative agent is antibiotic resistant.

Hence, it is important to prevent VAP infections by replacing the non-coated endotracheal tubes with coated endotracheal tubes. Endotracheal tubes if coated with antibiotic agents such as drugs and silver, will prevent the growth of microorganisms during ventilation. Therefore, increase in incidence of VAP is projected to upsurge the need of coated endotracheal tubes, thus boosting the market growth.
In the global Coated Endotracheal Tube market, This report focuses particularly in North America, South America, Europe and Asia-Pacific, and Middle East and Africa. This report classifies the market on the basis of application, type, regions, and manufactures.

In global market, the following companies are covered:
C.R. Bard
Bactiguard Holding AB
Enox Biopharma
Hospiteknik Healthcare
Innovative Surface Technologies
N8 Medical, LLC
Sharklet Technologies
Sonoma Pharmaceuticals
Teleflex Incorporated
Venner Medical International

Market Segment by Product Type
Orotracheal Intubation
Nasotracheal Intubation

Market Segment by Application
Anesthesia
Emergency Medicine
Others

Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)

The research provides answers to the following key questions:
• What is the estimated growth rate and market share and size of the Coated Endotracheal Tube market for the forecast period 2020 - 2025?
• What are the driving forces in the Coated Endotracheal Tube market for the forecast period 2020 - 2025?
• Who are the prominent market players and how have they gained a competitive edge over other competitors?
• What are the market trends influencing the progress of the Coated Endotracheal Tube industry worldwide?
• What are the major challenges and threats restricting the progress of the industry?
• What opportunities does the market hold for the prominent market players?